Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 å resolution

Structure

Volumn 2, Issue 8, 1994, Pages 767-777

  Sharma, Amit ^a   Hanai, Ryo ^b   Mondragón, Alfonso ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Amino terminal fragment; eukaryotic topoisomerases; Vaccinia virus DNA topoisomerase I; X ray structure

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; EUKARYOTIC CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; VACCINIA VIRUS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMAL; CAMPTOTHECIN; COMPARATIVE STUDY; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DNA MUTATIONAL ANALYSIS; DNA TOPOISOMERASES, TYPE I; EUKARYOTIC CELLS; HUMAN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, U.S. GOV'T, P.H.S.; VACCINIA VIRUS;

ANIMALIA; EUKARYOTA; VACCINIA; VACCINIA VIRUS;

EID: 0028774040     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(94)00077-8     Document Type: Article

References (42)

1. DNA topoisomerases
2. DNA topoisomerases
3. DNA topoisomerases: why so many?
4. Purification and characterization of DNA topoisomerase V
5. Alignment of primary sequences of DNA topoisomerases
6. Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I
7. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eukaryotic type I enzyme
8. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase
9. Mapping the active site tyrosine of vaccinia virus DNA topoisomerase I
10. Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli
11. Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA
12. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I
13. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I
14. Repeated seeding techniques for growing large single crystals of proteins
15. Diffraction methods for biological macromolecules: Seeding enlargement and repeated seeding
16. Cryocrystallography of biological macromolecules: a generally applicable method
17. Protein, DNA, and virus crystallography with a focused imaging proportional counter
18. A system for collection and on-line integration of X-ray diffraction data from a multiwire area detector
19. Mounting of crystals for macromolecular crystallography in a free-standing thin film
20. Improved methods for building protein models in electron density maps and the location of errors in these models
21. Crystallographic R factor refinement by molecular dynamics
22. The free r value: a novel statistical quantity for assessing the accuracy of crystal structures
23. Experience with the application of Patterson Search Techniques. Molecular replacement
24. Phenotypic selection and characterization of mutant alleles of a eukaryotic DNA topoisomerase I.
25. Expression of yeast DNA topoisomerase I can complement a conditional-lethal DNA topoisomerase I mutation in Escherichia coli
26. Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function
27. Expression of human type I and II DNA topoisomerases and their derivatives in E. coli
28. Camptothecin induces protein–linked DNA breaks via mammalian DNA topoisomerase I
29. DNA topoisomerase poisons as antitumor drugs
30. An engineered mutant of vaccinia virus topoisomerase I is sensitive to the anti-cancer drug camptothecin
31. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine
32. Use of T7 RNA polymerase to direct expression of cloned genes
33. Sparse matrix sampling: a screening method for crystallization of proteins
34. Determination of molecular weight from protein crystals
35. Automatic indexing of rotation diffraction patterns
36. Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector
37. Maximum likelihood refinement of heavy atom parameters
38. Slow-cooling protocols for crystallographic refinement by simulated annealing
39. PROCHECK: a program to check the stereochemical quality of protein structures
40. A note on the heavy-atom method
41. SETOR: Hardware-lighted three dimensional solid model representations of macromolecules